Screening for CMV retinitis using chromatic discrimination thresholds and achromatic contrast sensitivity

British Journal of Ophthalmology

Volumn 84, Issue 8, 2000, Pages 877-880

  Newsom, Richard S B ^a   Ong, Gek L ^a,b   Jackson, Tim L ^a   Coldrick, Ian ^a   Ripley, Lionel G ^b   Fisher, Martin ^c   Casswell, Anthony G ^a  

^a SUSSEX EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR VISION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; EYE FUNDUS; EYE PHOTOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; PRIORITY JOURNAL; RETINA; RETINITIS; SCREENING TEST; SLIT LAMP; STATISTICAL ANALYSIS; VISUAL ACUITY; VISUAL DISORDER;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CASE-CONTROL STUDIES; COLOR PERCEPTION; COLOR VISION DEFECTS; CONTRAST SENSITIVITY; CYTOMEGALOVIRUS RETINITIS; HIV INFECTIONS; HUMANS; MASS SCREENING; VISUAL ACUITY;

EID: 0033895180     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.8.877     Document Type: Article

References (26)

1. Gallant J, Moore R, Richmann D, et al. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with Zidovudine, The Zidovudine Epidemology Study Group. J Infect Dis 1992;166:1223-7.
2. Jabs D. Treatment of cytomegalovirus-1992. Arch Ophthalmol/1992;112:1531-9.
3. Kupperman B, Petty J, Richman D, et al. The correlation between CD4+ counts and the prevalence of cytomegalovirus retinitis and human immunodeficiency virus related non-infectious retinal vasculopathy in patients with the acquired immune deficiency syndrome. Am J Ophthalmol 1993;115:575-82.
4. Omerod L, Rhodes R, Gross S, et al. Ophthaltnologic manifestations of acquired immunedeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ophthalmology 1996;103:899-906.
5. Studies of the Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Study Group. Mortality in patients with the acquired immunedeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992;326:213-20.
6. Dodt K, Jacobsen P, Hofmann B, et al. Development of cytomegalovirus (CMV) disease may be predicted in HIV+ patients by CMV polymerase chain reaction and the antigenemia test. AIDS 1997;11:F21-8.
7. Bowen E, Wilson P, Cope A, et al. Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival, AIDS 1996;10:1515-20.
8. McCann J, Margolis T, Wong M, et al. A sensitive and specific laboratory assay for the diagnosis of cytomegalovirus retinitis. Am J Ophthalmol 1995;120:219-26.
9. Spector S, McKinley G, Lalezari J, et al. Oral ganciclovir for the prevention of cytomegalovirus in disease in persons with AIDS. N Engl J Med 1996;334:1491-7.
10. Shinkai M, Bozzette S, Powderley W, et al. Utility of urine and leucocyte cultures and plasma DNA polymerase chain reaction for the identification of AIDS patients at risk of developing human cytomegalovirus disease. J Infect Dis 1997;175:302-8.
11. Teich S, Saltzman B. Evaluation of a new self-screening chart for cytomegalovirus retinitis in patients with AIDS. J Acquir Immune Defic Synd Hum Retrovirol 1996;13:336-42.
12. Plummer D, Arevalo J, Fram N, et al. Effectiveness of entoptic perimetry for locating peripheral scotoma by cytomegalovirus retinits. Arch Ophthalmol 1996;114:828-31.
13. Latkany P, Holopigian K, Lorenzo-Latkany M, et al. Electroretinographic and psychophysical findings during early and late stages of human immunodeficiency virus infection and cytomegalovirus retinitis. Ophthalmology 1997;104:445-53.
14. Gellrich M, Kade G, Gerling J, et al. Pattern, flicker and flash electroretinography in human immunodeficiency virus infection: a longitudinal study. Ger J Ophthalmol 1996;5:16-22.
15. Geier S, Hammel G, Bogner J, et al. HIV-related ocular microangiopathic syndrome and colour contrast sensitivity. Invest Ophthalmol Vis Sci 1994;35:3011-21.
16. Mueller A, Plumber D, Dua R, et al. Analysis of visual dysfunctions in HIV+ patients without retinitis. Am J Ophthalmol 1997;124:158-67.
17. Tregear SJ, Knowles PJ, Ripley LG, et al. Colour vision deficits predict development of severe diabetic retinopathy in diabetic subjects with background retinopathy. Invest Ophthalmol Vis Sci 1993;34:719.
18. Tregear SJ, Knowles PJ, Ripley LG, et al. Automated tritan discrimination: a new clinical technique for the effective screening of severe diabetic retinopathy. Int J Psychophys 1994;16:191-8.
19. Tregear SJ, Knowles PJ, Ripley LG, et al. Chromatic-contrast threshold impairment in diabetes. Eye 1997;11:537-46
20. Cornsweet TN. The staircase method in psychophysics. Am J Psychol 1962;75:485-91
21. Quiceno J, Capparelli E, Sadun A, et al. Visual dysfunction without retinitis in patients with acquired immunedeficiency syndrome. Am J Ophthalmol 1992;113:8-13.
22. Jackson TL, Moate BJR, Knowles PJ, et al. Chromatic and achromatic contrast sensitivity in patients with HIV infection. Invest Ophthalmol Vis Sci 1997;March:Abstract 3.
23. Redfield R, Wright D, Tramount E. The Walter Reed staging for HTLV-III/LAV infection. N Engl J Med 1986;134:131-2.
24. Plummer D, Sample P, Arevalo J, et al. Visual field loss in HIV-positive patients without infectious retinopathy. Am J Ophthalmol 1996;122:542-9.
25. Greenstein V, Starter B, Hood B, et al. Hue discrimination and S cone pathway sensitivity in early diabetic retinopathy. Invest Ophthalmol Vis Sci 1990;103;1317-24.
26. Jacobson M, Zegans M, Pavan P, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443-5.